Immuno-Oncology Drugs Market Size, Share And Growth Analysis For 2024-2033

April 25, 2024 02:20 PM AEST | By EIN Presswire
 Immuno-Oncology Drugs Market Size, Share And Growth Analysis For 2024-2033
Image source: EIN Presswire

LONDON, GREATER LONDON, UK, April 2, 2024 /EINPresswire.com/ -- The global market reports from The Business Research Company have been updated with the most recent market sizing data for 2024 and projections extended to 2033

The Business Research Company’s “Immuno-Oncology Drugs Global Market Report 2024" is a comprehensive source of information that covers every facet of the market. As per TBRC’s market forecast, the immuno-oncology drugs market size is predicted to reach $175.05 billion in 2028 at a compound annual growth rate (CAGR) of 13.5%.

The growth in the immuno-oncology drugs market is due to the rise in the number of cancer cases across the globe. North America region is expected to hold the largest immuno-oncology drugs market share. Major players in the immuno-oncology drugs market include F. Hoffmann-La Roche Ltd., Merck & Co., Bristol-Myers Squibb Company, Amgen Inc., Johnson & Johnson, AstraZeneca PLC.

Immuno-Oncology Drugs Market Segments
•By Type: Immune Checkpoint Inhibitors, Immune System Modulators, Other Monoclonal Antibodies, Cancer Vaccines, Others
•By Therapeutic Application: Melanoma, Lung Cancer, Blood Cancer, Renal Cell Carcinoma, Bladder Cancer, Other Therapeutic Application
•By End-Users: Hospitals, Clinics, Ambulatory Surgical Centers, Others
•By Geography: The global immuno-oncology drugs market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Learn More On The Market By Requesting A Free Sample (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=3455&type=smp

Immuno-oncology drugs refer to a therapy or cancer treatment that employs drugs to either boost or suppress the immune system in order to aid the body's defenses against cancer, infection, and other disorders. It makes use of chemicals produced by the body or in a lab to strengthen the immune system and assist the body in locating and eliminating cancer cells.

The main types of immuno-oncology drugs market are monoclonal antibodies, immune checkpoint inhibitors, immune system modulators, cancer vaccines, and others. Monoclonal antibodies are created by cloning a single white blood cell. Every subsequent antibody generated in this manner may be traced back to a single parent cell. The different therapeutic applications include melanoma, lung cancer, blood cancer, renal cell carcinoma, prostate cancer, bladder cancer, and others and involve various sectors such as hospitals, clinics, ambulatory surgical centers, and cancer research institutes.

Read More On The Immuno-Oncology Drugs Global Market Report At:
https://www.thebusinessresearchcompany.com/report/immuno-oncology-drug-global-market-report

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Immuno-Oncology Drugs Market Characteristics
3. Immuno-Oncology Drugs Market Trends And Strategies
4. Immuno-Oncology Drugs Market – Macro Economic Scenario
5. Immuno-Oncology Drugs Market Size And Growth
……
27. Immuno-Oncology Drugs Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Market
29. Immuno-Oncology Drugs Market Future Outlook and Potential Analysis
30. Appendix

Browse Through More Similar Reports By The Business Research Company:

Veterinary Laboratory Testing Services Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/veterinary-laboratory-testing-services-global-market-report

Veterinary Diagnostic Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/veterinary-diagnostic-equipment-global-market-report

Dermatitis Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/dermatitis-drugs-global-market-report

Contact Information
The Business Research Company: https://www.thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]

Check out our:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
Twitter
LinkedIn


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.